<!DOCTYPE html>
<html lang="en">
<head>
<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-GF9D1BYMNK"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-GF9D1BYMNK');
</script>

<!-- ===========================
     FAVICONS (PNG)
     =========================== -->
<link rel="icon" type="image/png" sizes="16x16" href="16.png">
<link rel="icon" type="image/png" sizes="32x32" href="32.png">
<link rel="icon" type="image/png" sizes="48x48" href="48.png">
<link rel="icon" type="image/png" sizes="64x64" href="64.png">
<link rel="icon" type="image/png" sizes="128x128" href="128.png">
<link rel="icon" type="image/png" sizes="256x256" href="256.png">
<link rel="icon" type="image/png" sizes="512x512" href="512.png">

<!-- ===========================
     iOS / APPLE TOUCH ICONS
     =========================== -->
<link rel="apple-touch-icon" sizes="57x57" href="apple-touch-icon-57x57.png">
<link rel="apple-touch-icon" sizes="114x114" href="apple-touch-icon-114x114.png">
<link rel="apple-touch-icon" sizes="120x120" href="apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" sizes="180x180" href="apple-touch-icon-180x180.png">
<link rel="apple-touch-icon" href="apple-touch-icon.png"> <!-- Default fallback -->

<!-- ===========================
     WEB APP MANIFEST
     =========================== -->
<link rel="manifest" href="site.webmanifest">


  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Hyperacusis Guide - Tinnitus</title>
  <meta name="description" content="Explore tinnitus causes, symptoms, and treatments, from sound therapy and CBT to experimental bimodal devices, with insights for hyperacusis patients.">
  <meta property="og:image" content="https://www.hyperacusisguide.org/512.png" />
  <script>
    (function() {
        const THEME_KEY = 'userTheme';
        const html = document.documentElement;
        
        // --- DEFINING PATHS as RELATIVE (as confirmed) ---
        const DARK_LOGO_PATH = 'hg.png'; 
        const LIGHT_LOGO_PATH = 'hg-light.png'; 
        
        let storedTheme = localStorage.getItem(THEME_KEY);
        let targetTheme = storedTheme;
        
        // 1. Determine the required theme (User choice > System default)
        if (!targetTheme) {
            targetTheme = window.matchMedia('(prefers-color-scheme: dark)').matches ? 'dark' : 'light';
        }

        // 2. Apply theme class instantly (NO WAITING NEEDED for <html>)
        if (targetTheme === 'light') {
            html.classList.add('light-mode');
        } else {
            html.classList.remove('light-mode');
        }

        // 3. Set the logo source AFTER the DOM has loaded the <img> element.
        // We use DOMContentLoaded here to be absolutely sure the element is available.
        document.addEventListener('DOMContentLoaded', () => {
            const logo = document.querySelector('.logo-image');
            if (logo) {
                if (targetTheme === 'light') {
                    logo.src = LIGHT_LOGO_PATH;
                } else {
                    logo.src = DARK_LOGO_PATH;
                }
            }
        });
    })();
</script>

  <link rel="stylesheet" href="styles.css">


  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Ephesis&display=swap" rel="stylesheet">

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Poppins:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap" rel="stylesheet">

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Figtree:ital,wght@0,300..900;1,300..900&display=swap" rel="stylesheet">

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Raleway:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
</head>
<body>
    <div id="copy-overlay">
  <div id="copy-message">Link copied</div>
</div>
  <a id="top"></a> 
  <header>
    <div class="h-width">
    <h1 class="logo">
    <img src="hg.png" class="logo-image"><span class="guide-word"><span class="a">hyperacusis</span><span class="glow"><span class="g"> g</span><span class="u">u</span><span class="i">i</span><span class="d">d</span><span class="e">e</span></span></span></h1>
<div class="dark-mode-align" id="dark-mode-toggle">
    <svg class="dark-icon-size" viewBox="0 0 24 24" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
    <!-- Uploaded to: SVG Repo, www.svgrepo.com, Generator: SVG Repo Mixer Tools -->
    <title>ic_fluent_dark_theme_24_regular</title>
    <desc>Created with Sketch.</desc>
    
    <g id="🔍-Product-Icons" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
        <g class="dark-mode" id="ic_fluent_dark_theme_24_regular" fill-rule="nonzero">
            <path d="M12,22 C17.5228475,22 22,17.5228475 22,12 C22,6.4771525 17.5228475,2 12,2 C6.4771525,2 2,6.4771525 2,12 C2,17.5228475 6.4771525,22 12,22 Z M12,20.5 L12,3.5 C16.6944204,3.5 20.5,7.30557963 20.5,12 C20.5,16.6944204 16.6944204,20.5 12,20.5 Z">

</path>
        </g>
    </g>
</svg>
</div>
</div>
<div class="border" id="hamburger-wrapper">
  <button id="hamburger" aria-label="Menu">
    <span></span>
    <span></span>
    <span></span>
  </button>
</div>
  </header>
  <nav id="sidebar">
    <ul>
      <li><a href="index.html">Precautionary Guide</a></li>
      <li><a href="tinnitus.html">Tinnitus</a></li>
      <li><a href="hyperacusis.html">Hyperacusis</a></li>
      <li><a href="mem.html">MEM & TTTS</a></li>
      <li><a href="imaging.html">Diagnostic Imaging</a></li>
      <li><a href="medications.html">Medications & Botox</a></li>
      <li><a href="silverstein.html">Silverstein Procedure</a></li>
      <li><a href="patch.html">Paper Patching</a></li>
      <li><a href="community.html">Community & Resources</a></li> 
      <li><a href="about.html">About</a></li>
      <li><a href="contact.html">Contact</a></li> 
      <li class="icon-item"><a class="no-decoration" href="https://discord.gg/wd4zWZ6fRf" target="_blank" rel="noopener noreferrer"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg">
<path d="M20.317 4.4921C18.7873 3.80147 17.147 3.29265 15.4319 3.00122C15.4007 2.9956 15.3695 3.00965 15.3534 3.03777C15.1424 3.40697 14.9087 3.88862 14.7451 4.26719C12.9004 3.99545 11.0652 3.99545 9.25832 4.26719C9.09465 3.8802 8.85248 3.40697 8.64057 3.03777C8.62449 3.01059 8.59328 2.99654 8.56205 3.00122C6.84791 3.29172 5.20756 3.80054 3.67693 4.4921C3.66368 4.49772 3.65233 4.5071 3.64479 4.51928C0.533392 9.09311 -0.31895 13.5545 0.0991801 17.9606C0.101072 17.9822 0.11337 18.0028 0.130398 18.0159C2.18321 19.4993 4.17171 20.3998 6.12328 20.9967C6.15451 21.0061 6.18761 20.9949 6.20748 20.9695C6.66913 20.3492 7.08064 19.6952 7.43348 19.0073C7.4543 18.967 7.43442 18.9192 7.39186 18.9033C6.73913 18.6597 6.1176 18.3626 5.51973 18.0253C5.47244 17.9981 5.46865 17.9316 5.51216 17.8997C5.63797 17.8069 5.76382 17.7104 5.88396 17.613C5.90569 17.5952 5.93598 17.5914 5.96153 17.6026C9.88928 19.3672 14.1415 19.3672 18.023 17.6026C18.0485 17.5905 18.0788 17.5942 18.1015 17.612C18.2216 17.7095 18.3475 17.8069 18.4742 17.8997C18.5177 17.9316 18.5149 17.9981 18.4676 18.0253C17.8697 18.3692 17.2482 18.6597 16.5945 18.9024C16.552 18.9183 16.533 18.967 16.5538 19.0073C16.9143 19.6942 17.3258 20.3483 17.7789 20.9686C17.7978 20.9949 17.8319 21.0061 17.8631 20.9967C19.8241 20.3998 21.8126 19.4993 23.8654 18.0159C23.8834 18.0028 23.8948 17.9831 23.8967 17.9616C24.3971 12.8676 23.0585 8.4428 20.3482 4.52021C20.3416 4.5071 20.3303 4.49772 20.317 4.4921ZM8.02002 15.2778C6.8375 15.2778 5.86313 14.2095 5.86313 12.8976C5.86313 11.5857 6.8186 10.5175 8.02002 10.5175C9.23087 10.5175 10.1958 11.5951 10.1769 12.8976C10.1769 14.2095 9.22141 15.2778 8.02002 15.2778ZM15.9947 15.2778C14.8123 15.2778 13.8379 14.2095 13.8379 12.8976C13.8379 11.5857 14.7933 10.5175 15.9947 10.5175C17.2056 10.5175 18.1705 11.5951 18.1516 12.8976C18.1516 14.2095 17.2056 15.2778 15.9947 15.2778Z"/>
</svg></a></li> 
    </ul>
  </nav>

  <main>
    <article>
     <h1>Tinnitus  <i class="fas fa-link link-icon" data-anchor="top" onclick="copyAnchorLink(this)"></i></h1>

    <p class="lead">
Tinnitus is the perception of sound in the ears or head without an external source. It can present as ringing, buzzing, hissing, clicking, or other noises. Tinnitus may be temporary or chronic, can affect one or both ears, and ranges in severity from mild to extremely debilitating. It can arise from multiple factors, including loud noise exposure, acoustic trauma, ear infections, medication effects, and neurological disorders.     
     While it is often 
      associated with hearing loss, it can also occur in individuals with normal hearing and is <strong>very common in patients with hyperacusis</strong>. When tinnitus occurs alongside hyperacusis, it often presents as <strong>reactive tinnitus</strong>, meaning it intensifies immediately in response to sounds that exceed one’s tolerance threshold. 
      
    </p>
    <p>
    Many individuals with hyperacusis also report experiencing atypical auditory phenomena such as <strong>musical tinnitus</strong> and <strong>palinacousis</strong>. Musical tinnitus involves the perception of music or melodies without an external source.
    
    Palinacousis is a phenomenon in which a sound persists or replays after the external stimulus has ceased. For instance, one might hear the blare of an ambulance siren and continue to perceive the sound internally even after the ambulance has passed and the environment is silent.
    </p>

    <h2>Key Features of Tinnitus</h2>
    <ul class="features">
      <li>Perception of sound without an external source (ringing, buzzing, hissing, or clicking).</li>
      <li>Can affect one or both ears.</li>
      <li>May be continuous, intermittent, or pulsatile (rhythmic with heartbeat).</li>
      <li>Severity ranges from mild awareness to significant disruption of daily life and sleep.</li>
      <li>Often arises from loud noise exposure, acoustic trauma, ear infections, or medication effects.</li>
      <li>Very common in hyperacusis patients, often presenting as reactive tinnitus.</li>
      <li>Diagnosis is primarily clinical, often involving audiological testing and medical evaluation.</li>
      <li>Management may include sound therapy, counseling, stress reduction, or medical interventions.</li>
    </ul>
<a id="shore"></a>
<p>
<i>Most people with hyperacusis have normal hearing test results, and these tests rarely change how the condition is managed. Because the pure tones used during testing can significantly worsen hyperacusis or tinnitus, we recommend avoiding hearing tests unless they are truly necessary. Unfortunately, many ENT specialists require a hearing test before offering care, especially those who have limited experience treating hyperacusis.</i>
</p>

    <div class="page-break" aria-hidden="true"></div>

    <h1>Susan Shore Device <i class="fas fa-link link-icon" data-anchor="shore" onclick="copyAnchorLink(this)"></i></h1>

      <p class="lead">
    The <a class="link" href="https://www.tinnitushub.com/dr-susan-shore-auricle-questions-answers/" target="_blank" rel="noopener noreferrer">Susan Shore device</a>, developed at the University of Michigan, is an experimental treatment 
    for tinnitus that uses a technique known as bimodal neuromodulation. 
    This approach combines precisely timed sounds with mild electrical stimulation of the face or neck 
    to retrain the brain’s auditory pathways and reduce tinnitus perception. 
    The device is currently undergoing clinical testing and has shown 
    promising results in reducing tinnitus loudness and annoyance
    for certain individuals, particularly those whose tinnitus changes with jaw or neck movement.
  </p>

  <h2>Key Features</h2>
  <ul>
    <li>Combines sound stimulation with mild electrical impulses to the skin or neck.</li>
    <li>Aims to “desynchronize” overactive neural patterns linked to tinnitus.</li>
    <li>Developed by Dr. Susan Shore and her team at the University of Michigan.</li>
    <li>Most effective in individuals with somatic tinnitus (tinnitus influenced by head, jaw, or neck movement).</li>
    <li>Clinical trials have shown reductions in both tinnitus loudness and distress in some patients.</li>
    <li>Not yet commercially available, but FDA review and future distribution are anticipated.</li>
  </ul>
  <a id="lenire"></a>
        <p>
      The latest information and Q&A regarding the official Susan Shore device <a class="link" href="https://tinnitusquest.com/events/auricle-update/?gad_source=1&gad_campaignid=22632943177&gbraid=0AAAAA_lEsuzLbmoBDIvhRCssy5hMEHZFh&gclid=CjwKCAiAzrbIBhA3EiwAUBaUdRH17IwgkiUeUrccfgYlinaVRxtzoP-wJfLyY0lIketxaZmnLFKkDBoCSXEQAvD_BwE" target="_blank" rel="noopener noreferrer">can be found here</a>.
      </p>

    <div class="page-break" aria-hidden="true"></div>

    <h1>Lenire Device <i class="fas fa-link link-icon" data-anchor="lenire" onclick="copyAnchorLink(this)"></i></h1>

      <p class="lead">
    The <a class="link" href="https://www.lenire.com/" target="_blank" rel="noopener noreferrer">Lenire device</a> is a tinnitus treatment developed by Neuromod Devices that uses 
    bimodal neuromodulation ─ a combination of sound stimulation and mild electrical impulses delivered to the tongue. 
    The goal is to retrain the brain’s auditory system and reduce the perception of tinnitus over time. 
    Lenire is one of the first commercially available bimodal stimulation devices for tinnitus and has been cleared for use 
    in Europe and the United States. However, clinical outcomes have been mixed, with some patients reporting 
    modest improvement and others experiencing little to no change in symptoms.
  </p>

    <h2>Key Features</h2>

  <ul>
    <li>Combines sound therapy through headphones with mild electrical stimulation to the tongue via a mouthpiece.</li>
    <li>Aims to promote neuroplastic changes that reduce tinnitus perception and distress.</li>
    <li>Treatment is typically administered under audiologist supervision and customized to the individual’s tinnitus profile.</li>
    <li>Sessions usually last 30–60 minutes and are performed daily over several weeks or months.</li>
    <li>Has received regulatory approval in the EU and FDA authorization in the United States.</li>
    <li>Clinical studies report variable results, with effectiveness differing widely among users.</li>
    <li>Some patients report temporary reduction in tinnitus loudness or annoyance, while others notice minimal or no benefit.</li>
  </ul>

  <p class="lead">
  While both the Susan Shore device and Lenire device use bimodal neuromodulation to target tinnitus, 
  early findings suggest notable differences in their approach and effectiveness. 
  The Susan Shore device delivers <strong>precisely timed electrical stimulation</strong> to the neck or face in coordination with sound, 
  directly targeting the <strong>dorsal cochlear nucleus</strong>, a key region involved in tinnitus generation. 
  </p>
  <a id="trt"></a>
  <p>
  The Lenire device, by contrast, delivers gentle electrical impulses to the tongue through a mouthpiece paired with sound therapy. 
  Although Lenire has received regulatory approval and is commercially available in some regions, 
  independent studies and user reports have shown mixed results, 
  with many patients experiencing only partial or temporary improvement, while others notice no benefit. 
  The Susan Shore device, still in clinical testing, aims to refine this approach with more precise timing and individualized calibration.
</p>

      <div class="page-break" aria-hidden="true"></div>

    <h1>Tinnitus Retraining Therapy (TRT) <i class="fas fa-link link-icon" data-anchor="trt" onclick="copyAnchorLink(this)"></i></h1>

    <p class="lead">
      Tinnitus retraining therapy (TRT) is a structured approach designed to help 
      individuals habituate to tinnitus and reduce its impact on daily life. Developed by <a class="link" href="https://www.pluralpublishing.com/author/pawel-j-jastreboff?srsltid=AfmBOoqFHye1HR7-vnnulHIxfvKqJhJyRzC23MXEl3E8BM3LJBKdejiD" target="_blank" 
        rel="noopener noreferrer">Dr. Pawel Jastreboff</a>, TRT combines <strong>counseling</strong> to reframe the perception of 
      tinnitus with <strong>sound therapy</strong> to promote auditory desensitization. The goal 
      is not to eliminate the tinnitus entirely, but to make it less noticeable and distressing over time.
    </p>

    <h2>Key Features</h2>
    <ul class="features">
      <li>Based on the neurophysiological model of tinnitus, which links perception and emotional response.</li>
      <li>Combines <strong>educational counseling</strong> with <strong>sound therapy</strong>.</li>
      <li>Sound therapy uses low-level background noise (white or pink noise) to reduce the contrast between tinnitus and the environment.</li>
      <li>Emphasizes <strong>habituation</strong>, teaching the brain to ignore tinnitus signals.</li>
      <li>Structured program which usually lasts several months to years, depending on severity and response.</li>
      <li>Individualized to each patient’s hearing profile, tinnitus characteristics, and lifestyle.</li>
      <li>Requires consistent use of sound therapy devices or environmental sound adjustments.</li>
      <li>Scientific evidence supporting its effectiveness remains limited.</li>
    </ul>

<p class="lead">
While tinnitus retraining therapy (TRT) is widely used and promoted, there is currently 
<strong>limited scientific evidence</strong> to conclusively demonstrate its effectiveness. 
Clinical studies have produced mixed results, and some reviews suggest that benefits may be 
largely due to <a id="cbt"></a><strong>placebo effects</strong>, <strong>counseling support</strong>, or <strong>natural habituation</strong> 
over time rather than the sound therapy itself. Patients considering TRT should be aware that 
outcomes can vary and that rigorous, large-scale studies supporting its efficacy remain scarce. A <a class="link" href="https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2734346" target="_blank" rel="noopener noreferrer">2019 randomized clinical trial</a> published in JAMA found no significant differences in outcomes between TRT, partial TRT, and standard of care.
</p>
      <div class="page-break" aria-hidden="true"></div>
    <h1>Cognitive Behavioral Therapy (CBT) <i class="fas fa-link link-icon" data-anchor="cbt" onclick="copyAnchorLink(this)"></i></h1>

    <p class="lead">
      Cognitive Behavioral Therapy (CBT) is a psychological approach that helps 
      individuals manage the distress, anxiety, and negative emotional responses associated with 
      tinnitus and hyperacusis. While CBT does not directly reduce 
      the perceived sound or sensitivity, it aims to improve coping strategies, reduce stress, and 
      change unhelpful thought patterns that can worsen symptom perception. CBT is often used in 
      combination with other therapies, such as sound therapy or counseling, to enhance overall quality of life.
    </p>

    <p>
    <h2>Key Features</h2>
    <ul class="features">
      <li>Helps patients identify and modify negative thoughts and beliefs about tinnitus or sound sensitivity.</li>
      <li>Reduces anxiety, stress, and emotional distress associated with chronic auditory symptoms.</li>
      <li>Teaches coping strategies to improve tolerance of sounds that trigger discomfort.</li>
      <li>May improve sleep quality, concentration, and overall daily functioning.</li>
      <li>Often combined with sound therapy, relaxation techniques, and lifestyle adjustments.</li>
      <li>Delivered individually, in groups, or via online programs and guided self-help materials.</li>
      <a id="jastreboff"></a>
      <li>Focuses on long-term habituation and reducing the perceived impact of tinnitus and hyperacusis on daily life.</li>
      <li>May reduce tinnitus-related distress even if the perceived sound remains unchanged.</li>
    </ul>

    </p>
      <div class="page-break" aria-hidden="true"></div>
      <h1>On Dr. Pawel Jastreboff <i class="fas fa-link link-icon" data-anchor="jastreboff" onclick="copyAnchorLink(this)"></i></h1>
<p>
  Tinnitus Retraining Therapy (TRT) was first introduced in 1993 by Dr. Pawel Jastreboff and Dr. Jonathan Hazell, based on Jastreboff's <a class="link" href="documents/jastreboff.pdf" target="_blank" rel="noopener noreferrer">neurophysiological model of tinnitus</a> published in 1990. Their 2004 textbook, 
  <a class="link" href="https://www.amazon.com/Tinnitus-Retraining-Therapy-Implementing-Neurophysiological/dp/0521088372" target="_blank" rel="noopener noreferrer"><i>Tinnitus Retraining Therapy: Implementing the Neurophysiological Model</i></a>, outlined the principles of TRT and helped 
  popularize the neurophysiological model, but its clinical effectiveness remains scientifically unproven and <a class="link" href="https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2734346" target="_blank" rel="noopener noreferrer">lacks conclusive supporting evidence</a>.
</p>

<p>
In 2014, <a class="link" href="documents/isolation.pdf" target="_blank" rel="noopener noreferrer">Drs. Pawel and Margaret Jastreboff published an article</a> which explicitly states that protecting from sound exposure leads to worsening of hyperacusis symptoms. The authors write:
</p>

<ul>
<p class="quote">

<i>
"There are very limited data in the literature on the results of hyperacusis treatment. According to anecdotal reports, treatment has taken two opposite directions. The most common approach is to advise patients to avoid sound and use ear protection. This approach is based on the reasoning that because patients became sensitive to sound, they are supposedly more susceptible to sound exposure and consequently require extra protection. Patients readily embrace this advice and begin to protect their ears, even to the extent of using earplugs in quiet environments. <strong>Unfortunately, this well-intended approach makes the auditory system even more sensitive to sound and further exacerbates hyperacusis</strong>.
</p>
<p>
  <div class="warning">
  <strong>Attention</strong>  
     <ul>
    <li>The closing sentence in the paragraph above was written as if it were a fact, but it is not supported by scientific evidence and should be regarded as a theory. In our opinion, this theory is flawed, and we do not believe that protecting from sound exposure is harmful.</li>
    </ul>
  </div>
</p>
<p class="quote">

The opposite approach to treating hyperacusis involves desensitization wherein patients are exposed to a variety of sounds. The desensitization approach has been promoted for some time with several protocols and types of sounds used."
</i>
</ul>
</p>

<p>
Every member of <i>Hyperacusis Guide</i> suffers from varying degrees of hyperacusis, noxacusis (pain hyperacusis), and tinnitus. In the early stages of our conditions, each of us attempted to follow the principles of tinnitus retraining therapy (TRT). Not only did these methods fail to bring improvement, but in several cases, they appeared to contribute to further worsening. Despite the widespread promotion of TRT within audiology, we believe the approach does not adequately address the complex reality of severe cases and often dismisses the experiences of those most profoundly affected.
</p>

<p>
In his 2004 textbook, <i>Tinnitus Retraining Therapy: Implementing the Neurophysiological Model</i>, Dr. Jastreboff suggests that some patients who do not respond to TRT are "inventing or exaggerating" their symptoms for financial gain or to obtain disability benefits. On page 138, the textbook states the following:
</p>



<ul>
<p class="quote">
<i>
"Patients involved in litigation, or whose income depends on the continued experience of tinnitus/hyperacusis (i.e., disability payments), typically show very slow progress or no progress at all. Putting aside the possibility of inventing or exaggerating their symptoms because of potential financial gain, these patients are constantly being interviewed by different doctors and lawyers, which brings tinnitus/hyperacusis constantly to their attention, reinforcing its negative aspects, especially feelings of anger and grievance. This works directly against the approach and principles of TRT.
</p>
<p class="quote">
Subconsciously, the awareness that tinnitus distress may enhance any payments or income/disability received through the legal process can also militate against habituation of tinnitus. It is essential to ask patients about impending litigation and to warn them about the possibility of a negative impact on treatment. When appropriate, it is advisable to counsel patients about the benefits of avoidance or speedy conclusion of legal activity, after which TRT can proceed as in other patients."
</i>
</ul>
</p>

<p>In reality, while some individuals with hyperacusis or tinnitus may be eligible for short-term disability benefits through their employer, Social Security Disability Insurance (SSDI) does not recognize hyperacusis and tinnitus as disorders which qualify for long-term disability benefits.
At <i>Hyperacusis Guide</i>, we are not aware of a single case in which an individual has successfully received SSDI benefits for hyperacusis or tinnitus.
</p>

<p>
The severity of hyperacusis and tinnitus cannot currently be measured through objective diagnostic methods, aside from the <a class="link" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8901946/" target="_blank" rel="noopener noreferrer">Loudness Discomfort Level (LDL) test</a>, which is often unsafe or intolerable for individuals with severe hyperacusis. Consequently, clinical evaluations depend largely on patients’ subjective reports, making it impossible to conclusively prove or disprove an "expert’s" assessment. The absence of objective diagnostic criteria makes it particularly difficult to challange the opinions of "experts" such as Dr. Jastreboff.
</p>

      <p>
      For a clearer understanding of Dr. Jastreboff’s opinion on tinnitus and hyperacusis sufferers, please take a moment to review the series of video excerpts below where he explains, rather candidly, which patients he feels are unlikely to respond to tinnitus retraining therapy (TRT) ─ implying that they may have a hidden agenda such as social attention or financial gain. <a class="link" href="https://youtu.be/11SUmiq3UCU" target="_blank" 
        rel="noopener noreferrer">The full video can be found here</a>. At <i>Hyperacusis Guide</i>, we contend that Dr. Jastreboff’s approach has caused lasting damage to the advancement of tinnitus and hyperacusis research.
      </p>
      <p>
       <img src="Jastreboff/1.jpeg" class="full-width-image">
       <img src="Jastreboff/2.jpeg" class="full-width-image">
       <img src="Jastreboff/3.jpeg" class="full-width-image">
       <img src="Jastreboff/4.jpeg" class="full-width-image">
       <img src="Jastreboff/5.jpeg" class="full-width-image">
       <img src="Jastreboff/6.jpeg" class="full-width-image">
       <img src="Jastreboff/7.jpeg" class="full-width-image">
       <img src="Jastreboff/8.jpeg" class="full-width-image">
       <img src="Jastreboff/9.jpeg" class="full-width-image">
       <img src="Jastreboff/10.jpeg" class="full-width-image">
       <img src="Jastreboff/11.jpeg" class="full-width-image">
       <img src="Jastreboff/12.jpeg" class="full-width-image">
       <img src="Jastreboff/13.jpeg" class="full-width-image">
       <img src="Jastreboff/14.jpeg" class="full-width-image">
       <img src="Jastreboff/15.jpeg" class="full-width-image">
       <img src="Jastreboff/16.jpeg" class="full-width-image">
       <img src="Jastreboff/17.jpeg" class="full-width-image">
       <img src="Jastreboff/18.jpeg" class="full-width-image">
       <img src="Jastreboff/19.jpeg" class="full-width-image">
       <img src="Jastreboff/20.jpeg" class="full-width-image">
       <img src="Jastreboff/21.jpeg" class="full-width-image">
       <img src="Jastreboff/22.jpeg" class="full-width-image">
       <img src="Jastreboff/23.jpeg" class="full-width-image">
       <img src="Jastreboff/24.jpeg" class="full-width-image">
       <img src="Jastreboff/25.jpeg" class="full-width-image">
       <img src="Jastreboff/26.jpeg" class="full-width-image">
       <img src="Jastreboff/27.jpeg" class="full-width-image">
       <img src="Jastreboff/28.jpeg" class="full-width-image">
    </p>
    <a id="tribute"></a>
      <div class="page-break" aria-hidden="true"></div>
      <h1>A Tribute to Those Lost <i class="fas fa-link link-icon" data-anchor="tribute" onclick="copyAnchorLink(this)"></i></h1>

    <p>
 For some individuals, the experience of severe hyperacusis and tinnitus can become overwhelmingly distressing, reaching a point where the emotional and physical burden feels unbearable. In tragic cases, this has led some to take their own lives. The <a class="link" href="https://brewoods.wixsite.com/hyperacusismemorial" target="_blank" rel="noopener noreferrer">Hyperacusis Wall of Remembrance</a> serves as a solemn tribute to those lost, illustrating the profound impact these conditions can have and underscoring the urgent need for greater understanding, compassion, and research.
 </p>
</article>
<a href="#top" class="back-to-top" aria-label="Back to top"></a>
  </main>
  
  <script src="script.js"></script>
</body>
</html>
